XML 34 R12.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments
 12 Months Ended
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Investments Investments
Investments consist of the following:
As of December 31,
20242023
Equity method investments$245,567 $228,822 
Other investments12,240 11,380 
Total investments$257,807 $240,202 
As of December 31, 2024 and 2023, the Company held investments of $257.8 million and $240.2 million, respectively, of which $49.0 million and $56.1 million were owned by noncontrolling interest holders, respectively. Future net income (loss) and cash flow from investments held by noncontrolling interest holders will not be attributable to the Company.
Equity Method Investments
The summarized financial information of the Company’s equity method investments is as follows:
As of December 31,
20242023
Total assets
$46,382,280 $42,312,866 
Total liabilities
$1,771,980 $1,357,554 
Total equity
$44,610,300 $40,955,312 
Year Ended December 31,
202420232022
Investment income
$243,222 $187,989 $109,180 
Expenses
395,748 347,320 304,908 
Net investment loss
(152,526)(159,331)(195,728)
Net realized and unrealized gain
2,737,015 1,831,634 1,108,471 
Net income
$2,584,489 $1,672,303 $912,743 
The Company evaluates each of its equity method investments to determine if any were significant as defined by the SEC. As of December 31, 2024 and 2023, no individual equity method investment held by the Company met the significance criteria. As such, the Company is not required to present separate financial statements for any of its equity method investments.
Other Investments
See Note 5 for fair value disclosures of certain investments held within other investments. The Company holds $0.2 million in held to maturity investments held within other investments.